Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers
Abstract KRAS is one of the most frequently mutated oncogenes across various cancers. Oncogenic KRAS mutations rewire cellular signaling, leading to significant alterations in gene expression. RNA-binding proteins (RBPs) play a pivotal role in gene expression regulation by post-transcriptionally con...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-78333-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850061772123275264 |
|---|---|
| author | Ka-Yun Ban Yong-woo Na Juhan Song Jong-Seo Kim Jimi Kim |
| author_facet | Ka-Yun Ban Yong-woo Na Juhan Song Jong-Seo Kim Jimi Kim |
| author_sort | Ka-Yun Ban |
| collection | DOAJ |
| description | Abstract KRAS is one of the most frequently mutated oncogenes across various cancers. Oncogenic KRAS mutations rewire cellular signaling, leading to significant alterations in gene expression. RNA-binding proteins (RBPs) play a pivotal role in gene expression regulation by post-transcriptionally controlling various aspects of RNA metabolism. It has become clear that interactions between RBPs and RNA are frequently dysregulated in numerous cancers. However, how oncogenic KRAS mutations reshape the post-transcriptional regulatory network mediated by RBPs remains poorly understood. In this study, we systematically dissected oncogenic KRAS-driven alterations of RNA-RBP networks. We identified 35 cancer-associated RBPs with either increased or decreased RNA binding upon oncogenic KRAS activation, including PDCD11, which is essential for the viability of KRAS mutant cancers, and ELAVL2, which regulates cell migration in KRAS mutant lung cancers. Our study serves as a crucial resource for elucidating RBP regulatory networks in KRAS mutant cancers and may provide new avenues for therapeutic strategies targeting KRAS mutant malignancies. |
| format | Article |
| id | doaj-art-aac83e4b03e942519bbde17cac7fb219 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-aac83e4b03e942519bbde17cac7fb2192025-08-20T02:50:07ZengNature PortfolioScientific Reports2045-23222024-11-0114111010.1038/s41598-024-78333-2Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancersKa-Yun Ban0Yong-woo Na1Juhan Song2Jong-Seo Kim3Jimi Kim4Department of Health Science and Technology, Lee Gil Ya Cancer and Diabetes Institute, GAIHSTSchool of Biological Sciences, Seoul National UniversityDepartment of Health Science and Technology, Lee Gil Ya Cancer and Diabetes Institute, GAIHSTSchool of Biological Sciences, Seoul National UniversityDepartment of Health Science and Technology, Lee Gil Ya Cancer and Diabetes Institute, GAIHSTAbstract KRAS is one of the most frequently mutated oncogenes across various cancers. Oncogenic KRAS mutations rewire cellular signaling, leading to significant alterations in gene expression. RNA-binding proteins (RBPs) play a pivotal role in gene expression regulation by post-transcriptionally controlling various aspects of RNA metabolism. It has become clear that interactions between RBPs and RNA are frequently dysregulated in numerous cancers. However, how oncogenic KRAS mutations reshape the post-transcriptional regulatory network mediated by RBPs remains poorly understood. In this study, we systematically dissected oncogenic KRAS-driven alterations of RNA-RBP networks. We identified 35 cancer-associated RBPs with either increased or decreased RNA binding upon oncogenic KRAS activation, including PDCD11, which is essential for the viability of KRAS mutant cancers, and ELAVL2, which regulates cell migration in KRAS mutant lung cancers. Our study serves as a crucial resource for elucidating RBP regulatory networks in KRAS mutant cancers and may provide new avenues for therapeutic strategies targeting KRAS mutant malignancies.https://doi.org/10.1038/s41598-024-78333-2 |
| spellingShingle | Ka-Yun Ban Yong-woo Na Juhan Song Jong-Seo Kim Jimi Kim Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers Scientific Reports |
| title | Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers |
| title_full | Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers |
| title_fullStr | Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers |
| title_full_unstemmed | Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers |
| title_short | Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers |
| title_sort | protein rna interaction dynamics reveal key regulators of oncogenic kras driven cancers |
| url | https://doi.org/10.1038/s41598-024-78333-2 |
| work_keys_str_mv | AT kayunban proteinrnainteractiondynamicsrevealkeyregulatorsofoncogenickrasdrivencancers AT yongwoona proteinrnainteractiondynamicsrevealkeyregulatorsofoncogenickrasdrivencancers AT juhansong proteinrnainteractiondynamicsrevealkeyregulatorsofoncogenickrasdrivencancers AT jongseokim proteinrnainteractiondynamicsrevealkeyregulatorsofoncogenickrasdrivencancers AT jimikim proteinrnainteractiondynamicsrevealkeyregulatorsofoncogenickrasdrivencancers |